Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Histone deacetylase inhibitors augment doxorubicin-induced DNA damage in cardiomyocytes
Authors
Keywords
-
Journal
CELLULAR AND MOLECULAR LIFE SCIENCES
Volume 68, Issue 24, Pages 4101-4114
Publisher
Springer Nature
Online
2011-05-17
DOI
10.1007/s00018-011-0727-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Quantifying pharmacologic suppression of cellular senescence: prevention of cellular hypertrophy versus preservation of proliferative potential
- (2016) Zoya N. Demidenko et al. Aging-US
- Growth and aging: a common molecular mechanism
- (2016) Mikhail V. Blagosklonny et al. Aging-US
- Trichostatin A accentuates doxorubicin-induced hypertrophy in cardiac myocytes
- (2016) Tom C Karagiannis et al. Aging-US
- Rapamycin decelerates cellular senescence
- (2011) Zoya N. Demidenko et al. CELL CYCLE
- Effect of valproic acid on radiation-induced DNA damage in euchromatic and heterochromatic compartments
- (2010) KN Harikrishnan et al. CELL CYCLE
- The clinical development of histone deacetylase inhibitors as targeted anticancer drugs
- (2010) Paul A Marks EXPERT OPINION ON INVESTIGATIONAL DRUGS
- Romidepsin: a new therapy for cutaneous T-cell lymphoma and a potential therapy for solid tumors
- (2010) Cliona Grant et al. Expert Review of Anticancer Therapy
- Nonhistone protein acetylation as cancer therapy targets
- (2010) Brahma N Singh et al. Expert Review of Anticancer Therapy
- Interaction of Daunomycin with Acetylated Chromatin
- (2010) Lyndsay Sprigg et al. JOURNAL OF MEDICINAL CHEMISTRY
- γH2AX: a sensitive molecular marker of DNA damage and repair
- (2010) L-J Mah et al. LEUKEMIA
- Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents
- (2010) M. Namdar et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Histone deacetylase inhibitor induces DNA damage, which normal but not transformed cells can repair
- (2010) J.- H. Lee et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Development of vorinostat: Current applications and future perspectives for cancer therapy
- (2009) Victoria M. Richon et al. CANCER LETTERS
- Enhancing the apoptotic and therapeutic effects of HDAC inhibitors
- (2009) Ailsa J. Frew et al. CANCER LETTERS
- H2AX: functional roles and potential applications
- (2009) Jennifer S. Dickey et al. CHROMOSOMA
- Rational Combinations Using HDAC Inhibitors
- (2009) M. Bots et al. CLINICAL CANCER RESEARCH
- Clinical and Biological Effects of Valproic Acid as a Histone Deacetylase Inhibitor on Tumor and Surrogate Tissues: Phase I/II Trial of Valproic acid and Epirubicin/FEC
- (2009) P. Munster et al. CLINICAL CANCER RESEARCH
- Histone deacetylase inhibitors: Potential in cancer therapy
- (2009) P.A. Marks et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- ERKs/p53 signal transduction pathway is involved in doxorubicin-induced apoptosis in H9c2 cells and cardiomyocytes
- (2008) Jiahao Liu et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Histone deacetylase inhibitors in lymphoma and solid malignancies
- (2008) Walid Rasheed et al. Expert Review of Anticancer Therapy
- Competitive or noncompetitive, that's the question: research toward histone deacetylase inhibitors
- (2008) H. Su et al. MOLECULAR CANCER THERAPEUTICS
- Induction of several cytochrome P450 genes by doxorubicin in H9c2 cells
- (2008) Beshay N.M. Zordoky et al. VASCULAR PHARMACOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now